Hypovitaminosis C Prevalence and Risk Factors in an Acute Geriatric Unit (HYPO-VIT-C)
Deficiency, Vitamin C
About this trial
This is an interventional other trial for Deficiency, Vitamin C focused on measuring Vitamin C, Hypovitaminosis C, Vitamin C depletion, Vitamin C deficiency, prevalence, risk factors, geriatrics, elderlies, acute care unit
Eligibility Criteria
Inclusion Criteria: All patient admitted in the geriatric study acute care unit Aged more than 75 years-old. Patient able to consent having signed a consent or patient unable to give consent, informed and not opposed to the study to the study and for whom a trustworthy person, or failing that family, or failing that, a close relative, has signed an informed informed consent Patient affiliated to a social security system Exclusion Criteria: More than 7 days of hospitalization prior to the admission in the study acute care unit. Patients at the end of their life. No biological sample will be collected Patients under a "sauvegarde de justice" procedurePatients under legal protection (guardianship, curatorship, "sauvegarde de justice" procedure), Patient unable to consent without a trusted person (or family, or close friends) or without a trusted person (or family, or close friend) available within 2 days after the patient's admission.
Sites / Locations
- Service de Médecine Gériatrique of the Hôpital Edouard Herriot (Pavillon K)Recruiting
Arms of the Study
Arm 1
Experimental
Elderly patients
Only one group of patients will be constituted. It will be composed of 453 patients aged more than 75 years old and hospitalized in a geriatric acute care unit. If the patient consent to participate in the study, a 4-mL blood sample will be collected concomitantly with a general laboratory evaluation that will be performed when the patient enters the unit. No other sample will be taken., and tThe participation of the patient to the study will end after the result of the test or after the end of the vitamin C supplementation. A telephone call is organized to follow up on any adverse effectswith this blood sample collection. No further visit is organised.